VNP40101M in Treating Patients With Advanced or Metastatic Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of VNP40101M in treating patients who have advanced or metastatic cancer.

DISEASE(S): Neoplasm Metastasis,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2008496 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR